Following the pharmaceutical industry’s recent warning on stockpiling critical medications due to Coronavirus and the uncertainty of Brexit looming on the horizon, the pharmaceutical supply chain faces a serious risk of disruption if contingency plans are not put in place.
Coronavirus has brought about some unexpected challenges for the pharmaceutical industry, with an unprecedented increase in demand for critical care respiratory medicines and inhalers – products which are not usually stockpiled or required in such large quantities.
Further to this, the lockdown restrictions laid out by the UK Government have caused significant delays in the supply chain as a result of factory closures, export restrictions and a reduction in air freight.
In a memo put together by a selection of pharmaceutical industry groups, they attribute the continuous flow of medicines has been kept going through the pandemic as a result of international coordination, information sharing and redirect manufacturing.
Putting in place a secondary supply chain is crucial to ensure the continuous flow of products and medications, and here at Technoprint we have a proven track record of acting as a critical second supplier to pharmaceutical companies.
We understand that last-minute amends to quantities and urgent jobs are unavoidable within the industry, and our closed-loop in-house production facility enables us to have complete sight of a job at any time. This enables us to offer a bespoke tailored service to pharmaceutical companies, depending on their needs.
If you’re interested in hearing more about our end-to-end printing and folding service of patient information leaflets, get in touch with a member of our team today.